Send us a text

In this episode, we explore the risks and scientific concerns surrounding GLP-1 receptor agonists, such as Wegovy and Zepbound, which are reshaping the weight loss and diabetes treatment markets. While these drugs show significant weight loss benefits, research reveals a troubling rebound effect when patients discontinue use, often leading to greater weight regain due to fat cell hyperplasia. Unlike the common yo-yo dieting effect, these medications can increase the number of fat cells in the body, making future weight management more challenging. Dr. Kiernan warns that without lasting lifestyle changes, users may face intensified fat accumulation, particularly in harmful visceral areas, exacerbating health risks.

Are you eager to explore more about health and wellness? Discover additional resources and connect with Dr. Urban A. Kiernan and his team. Plus, stay updated on the latest insights by following Dr. Kiernan on LinkedIn. Start your journey to better health today!

https://imbiopharma.com/
https://www.linkedin.com/in/urban-a-kiernan-ph-d-8568b621/
https://www.youtube.com/@DecodingHealthPodcast

Thank you to our sponsors:
Foresight Chiropractic: Maximizing human performance through regular spine care. Mention this podcast when you schedule to get a free consultation and discounted nervous system exam https://www.foresightchiropractic.com

Restore Health: Revitalize Your Performance. Unlock your athletic potential with Restore Health AZ. Our Restorative Injection Therapy and Anti-Aging Precision Medicine rebuilds your health naturally. Visit Restorehealthaz.com to take their pain quiz and get a free 10-minute consult with an expert.

iMetabolic Biopharma Corporation: Together, we can be the next stage in developing a revolutionary approach to drug discovery. We give communities the opportunity to invest in their own health as we improve how drugs are discovered to make them more effective and affordable. Visit https://imbiopharma.com/ to learn more.